Primary prophylactic treatment with implantable defibrillator in high risk patients
Møller, M.; Haghfelt, T.
Ugeskrift for Laeger 162(31): 4160-4161
2000
ISSN/ISBN: 0041-5782 PMID: 10962922 Document Number: 525827
Document emailed within 1 workday
Related Documents
Akhtar, M.; Avitall, B.; Jazayeri, M.; Tchou, P.; Troup, P.; Sra, J.; Axtell, K. 1992: Role of implantable cardioverter defibrillator therapy in the management of high-risk patients Circulation 85(1): I131-I139De Sousa, J. 2001: Identification of patients most likely to benefit from implantable cardioverter-defibrillator therapy--the Canadian Implantable Defibrillator Study Revista Portuguesa de Cardiologia: Orgao Oficial da Sociedade Portuguesa de Cardiologia 20(1): 109-110
Feldman, A.M.; Kersten, D.J.; Chung, J.A.; Asheld, W.J.; Germano, J.; Islam, S.; Cohen, T.J. 2015: Gender-Related and Age-Related Differences in Implantable Defibrillator Recipients: Results from the Pacemaker and Implantable Defibrillator Leads Survival Study ("PAIDLESS") Journal of Invasive Cardiology 27(12): 530-534
Garnero, S.; Pomero, A.; Vallauri, P.; Leto, L.; Testa, M.; Feola, M. 2014: The implantable cardioverter defibrillator in congestive heart failure patients in primary prevention: assessment of neuropsychological impact Minerva Cardioangiologica 62(4): 321-326
Chichareon, P.; Krittayaphong, R.; Yindeengam, A. 2015: Prevalence and predictors of appropriate implantable cardioverter defibrillator therapy in chronic left ventricular dysfunction patients for primary prevention of sudden cardiac death in Siriraj Hospital Journal of the Medical Association of Thailand 98(1): 14-20
Occhetta, E. 2000: The benefits of the implantable cardioverter-defibrillator in comparisons with anti-arrhythmia agents in patients surviving malignant ventricular tachyarrhythmias: a subanalysis of the AVID study by varying degrees of left ventricular dysfunction. Antiarrhythmic versus Implantable Defibrillators Italian Heart Journal. Suppl: Official Journal of the Italian Federation of Cardiology 1(4): 577-578
Pieragnoli, P.; Ricciardi, G.; Colella, A.; Musilli, N.; Porciani, M.C.; Giaccardi, M.; Padeletti, L.; Michelucci, A. 2006: Is implantable defibrillator indicated in all patients on cardiac resynchronization therapy? Minerva Cardioangiologica 54(6): 735-741
Suwanpasak, A.; Boonyapisit, W. 2014: The quality of life in implantable cardioverter defibrillator patients Journal of the Medical Association of Thailand 97(Suppl 3): S108-S114
Zaremba, T.; Thøgersen, A.M.; Jakobsen, A.R.; Hjortshøj, S.ør.P.ær.; Eschen, O.; Riahi, S. 2011: Radiotherapy in patients with a pacemaker or an implantable cardioverter defibrillator Ugeskrift for Laeger 173(36): 2195-2197
Silvetti, M.S. 2007: Pacemaker and implantable cardioverter defibrillator implantation in pediatric patients Minerva Cardioangiologica 55(6): 803-813
Mirowski, M.; Reid, P.R.; Mower, M.M.; Watkins, L.; Platia, E.V.; Griffith, L.S.; Juanteguy, J.M. 1984: Use of the automatic implantable cardioverter-defibrillator in the treatment of malignant ventricular tachyarrhythmias Herz 9(2): 83-89
Devecchi, P.; Plebani, L.; Occhetta, E.; Bortnik, M.; Francalacci, G.; Magnani, A.; Marino, P. 2006: Electrical storms in patients with implantable cardioverter-defibrillator: incidence and clinical management Giornale Italiano di Cardiologia 7(10): 695-701
Shan, Q-jun.; Yang, B.; Chen, M-long.; Zou, J-gang.; Xu, D-jie.; Chen, C.; Li, K-lin.; Zhu, P-jun.; Wang, X-bing.; Cao, K-jiang. 2005: The electrophysiological study and implantable cardioverter defibrillator therapy for the patients with Brugada syndrome Zhonghua Xin Xue Guan Bing Za Zhi 33(1): 34-36
Uretsky, B.F. 1997: Implantable defibrillators in patients with coronary artery disease at high risk for ventricular arrhythmia New England Journal of Medicine 336(23): 1677
Shiikawa, A.; Koyanagi, H.; Endo, M.; Yagi, Y.; Nakano, H.; Hayashi, K.; Yamazaki, K.; Akimoto, T. 1991: The automatic implantable cardioverter defibrillator--clinical experience in patients with life-threatening ventricular tachyarrhythmias Nihon Kyobu Geka Gakkai 39(3): 294-300
Baltás, B.; Nagy, A.; Baradnay, G.; Pepó, J. 1980: Experience with prophylactic cimetidine therapy in high risk patients Orvosi Hetilap 121(50): 3043-3047
Freeman, G.M. 1982: The efficacy of prophylactic antibiotics in high-risk patients undergoing cesarean section Journal of the American Osteopathic Association 81(9): 610-615
Strickberger, S.A.; Daoud, E.G.; Davidson, T.; Weiss, R.; Bogun, F.; Knight, B.P.; Bahu, M.; Goyal, R.; Man, K.C.; Morady, F. 1997: Probability of successful defibrillation at multiples of the defibrillation energy requirement in patients with an implantable defibrillator Circulation 96(4): 1217-1223
Geng, S.; Feng, F.-z.; Xiang, Y.; Wan, X.-r.; Zhou, Y. 2011: Analysis of prophylactic chemotherapy outcome and clinical characteristics in patients of high-risk hydatidiform mole Zhonghua Fu Chan Ke Za Zhi 46(1): 24-27
Borges, A.C.; Waldenberger, F.R.; Wolf, C.; Reindl, I.; Habedank, D.; Haisjackl, M.; Kox, W.J.; Konertz, W.; Baumann, G.; Kleber, F.X. 1996: Percutaneous "high risk" angioplasty with prophylactic cardiopulmonary support. High risk PTCA with mechanical circulatory support Zeitschrift für Kardiologie 85(Suppl 4): 21-28